SAN MATEO, Calif.–(BUSINESS WIRE)–Model N, Inc. (MODN), a leader in revenue optimization and compliance, today announced that Jason Blessing, Chief Executive Officer, will present at the JP Morgan 50th Annual Global Technology, Media & Communications Conference. The presentation is scheduled for Wednesday, May 25, 2022 at 5:40a.m. PT (8:40a.m. ET).
A webcast of the live and replay presentation will be accessible from the investor relations page of the Model N website at https://investor.modeln.com/.
About Model N
Model N is the leader in revenue optimization and compliance for pharmaceutical, medtech, and high-tech innovators. Our intelligent platform powers your digital transformation with integrated technology, data, analytics, and expert services that deliver deep insight and control. Our integrated cloud solution is proven to automate pricing, incentive, and contract decisions to scale business profitably and grow revenue. Model N is trusted across more than 120 countries by the world’s leading pharmaceutical, medical technology, semiconductor, and high-tech companies, including Johnson & Johnson, AstraZeneca, Stryker, Seagate Technology, Broadcom, and Microchip Technology. For more information, visit www.modeln.com.
Contacts
Investor Relations Contact:
Carolyn Bass
investorrelations@modeln.com
Media Contact:
Denyse Dabrowski
Bospar Public Relations
denyse@bospar.com
HeartBeam system was recently cleared by US Food and Drug Administration (FDA) for comprehensive arrhythmia…
ALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused…
This generous grant will directly benefit the NCCS's Beyond the Cure Ambassador Scholarship Program, which…
Medical Co-working space challenges broken healthcare system. HOUSTON, TEXAS / ACCESSWIRE / December 23, 2024…
SAN DIEGO, CALIFORNIA / ACCESSWIRE / December 23, 2024 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce"…
MIAMI, FL / ACCESSWIRE / December 23, 2024 / Telomir Pharmaceuticals, Inc. (NASDAQ:TELO), or the…